Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Wang, Cheng ^a   Yu, Jie ^a   Kallen, Caleb B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ESTRADIOL; LUCIFERASE; MESSENGER RNA; ANTIESTROGEN; DRUG DERIVATIVE; ESTROGEN RECEPTOR ALPHA; FULVESTRANT;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; ESTROGEN RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; TANDEM REPEAT; VALIDATION PROCESS; BIOLOGY; BREAST TUMOR; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSFECTION; UP-REGULATION;

EID: 55849085008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003523     Document Type: Article

References (87)

1. Waga S, Stillman B (1994) Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature 369:207-212.
2. Umar A, Buermeyer AB, Simon JA, Thomas DC, Clark AB, et al. (1996) Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87: 6573.
3. Maga G, Hubscher U (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 116: 3051-3060.
4. Warbrick E (2000) The puzzle of PCNA's many partners. Bioessays 22: 997-1006.
5. Waga S, Hannon GJ, Beach D, Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578.
6. Chuang LS, Ian HI, Koh TW, Ng HH, Xu G, et al. (1997) Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAFI. Science 277: 1996-2000.
7. Iida T, Suetake I, Tajima S, Morioka H, Ohta S, et al. (2002) PCNA clamp facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA. Genes Cells 7: 997-1007.
8. Hong R, Chakravarti D (2003) The human proliferating Cell nuclear antigen regulates transcriptional coactivator p300 activity and promotes transcriptional repression. J Biol Chem 278: 44505-44513.
9. Moldovan GL, Pfander B, Jentsch S (2007) PCNA, the maestro of the replication fork. Cell 129: 665-679.
10. Baserga R (1991) Growth regulation of the PCNA gene. J Cell Sci 98(Pt 4): 433-436.
11. Li YY, Wang L, Lu CD (2003) An E2F site in the 5′-promoter region contributes to serum-dependent up-regulation of the human proliferating cell nuclear antigen gene. FEBS Lett 544: 112-118.
12. Tommasi S, Pfeifer GP (1999) In vivo structure of two divergent promoters at the human PCNA locus. Synthesis of antisense RNA and S phase-dependent binding of E2F complexes in intron 1. J Biol Chem 274: 27829-27838.
13. Morris GF, Mathews MB (1989) Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264: 13856-13864.
14. Alder H, Yoshinouchi M, Prystowsky MB, Appasamy P, Baserga R (1992) A conserved region in intron 1 negatively regulates the expression of the PCNA gene. Nucleic Acids Res 20: 1769-1775.
15. Jaskulski D, Gatti C, Travali S, Calabretta B, Baserga R (1988) Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J Biol Chem 263: 10175-10179.
16. Almendral JM, Huebsch D, Blundell PA, Macdonald-Bravo H, Bravo R (1987) Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. Proc Natl Acad Sci U S A 84: 1575-1579.
17. Shipman-Appasamy P, Cohen KS, Prystowsky MB (1990) Interleukin 2-induced expression of proliferating cell nuclear antigen is regulated by transcriptional and post-transcriptional mechanisms. J Biol Chem 265: 19180-19184.
18. Morris GF, Bischoff JR, Mathews MB (1996) Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc Nat Acad Sci U S A 93: 895-899.
19. Kannabiran C, Morris GF, Mathews MB (1999) Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53. Oncogene 18: 7825-7833.
20. Chang CD, Ottavio L, Travali S, Lipson KE, Baserga R (1990) Transcriptional and posttranscriptional regulation of the proliferating cell nuclear antigen gene. Mol Cell Biol 10: 3289-3296.
21. Koniecki J, Nugent P, Kordowska J, Baserga R (1991) Effect of the SV40 T antigen on the posttranscriptional regulation of the proliferating cell nuclear antigen and DNA polymerase-alpha genes. Cancer Res 51: 1465-1471.
22. Schimmelpenning H, Eriksson ET, Franzen B, Zetterberg A, Auer GU (1993) Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive human mammary carcinomas. Virchows Arch A Pathol Anat Histopathol 423: 273-279.
23. Aaltomaa S, Lipponen P, Syrjanen K (1993) Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer. Anticancer Res 13: 533-538.
24. Narita T, Funahashi H, Satoh Y, Takagi H (1993) Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis. Jpn J Clin Oncol 23: 20-25.
25. Horita K, Yamaguchi A, Hirose K, Ishida M, Noriki S, et al. (2001) Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer. Eur J Histochem 45: 73-84.
26. Schonborn I, Zschiesche W, Minguillon C, Spitzer E, Mohner M, et at. (1995) Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer. J Cancer Res Clin Oncol 121: 115-122.
27. Sheen-Chen SM, Eng HL, Chou FF, Chen WJ (1997) The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer. Arch Surg 132: 264-267.
28. Kato T, Kimura T, Miyakawa R, Fujii A, Yamamoto K, et al. (2000) Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer. Br J Cancer 82: 404-411.
29. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354: 270-282.
30. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, et al. (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574.
31. Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, et al. (2008) Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol 4: 188.
32. Bourdeau V, Deschenes J, Metivier RI Nagal Y, Nguyen D, et al. (2004) Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol 18: 1411-1427.
33. Schultz-Norton JR, Gabisi VA, Ziegler YS, McLeod IX, Yates JR, et al. (2007) Interaction of estrogen receptor alpha with proliferating cell nuclear antigen. Nucleic Acids Res 35: 5028-5038.
34. Martin PJ, Lardeux V, Lefebvre P (2005) The proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct protein-protein interaction. Nucleic Acids Res 33: 4311-4321.
35. Labie C, Morris GF, Mathews MB (1993) A complex promoter element mediates transactivation of the human proliferating cell nuclear antigen promoter by the 243-residue adenovirus E1A oncoprotein. Mol Cell Biol 13: 1697-1707.
36. Kannabiran C, Morris GF, Labrie C, Mathews MB (1993) The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoter. J Virol 67: 507-515.
37. Labile C, Lee BH, Mathews MB (1995) Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter. Nucleic Acids Res 23: 3732-3741.
38. Liu M, Lee BH, Mathews MB (1999) Involvement of RFX1 protein in the regulation of the human proliferating cell nuclear antigen promoter. J Biol Chem 274: 15433-15439.
39. Lee BH, Mathews MB (1997) Transcriptional coactivator cAMP response element binding protein mediates induction of the human proliferating cell nuclear antigen promoter by the adenovirus E1A oncoprotein. Proc Nail Acad Sci U S A 94: 4481-4486.
40. Lee BH, Liu M, Mathews MB (1998) Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107. J Virol 72: 1138-1145.
41. Krieg AJ, Hammond EM, Giaccia AJ (2006) Functional analysis of p53 binding under differential stresses. Mol Cell Biol 26: 7030-7045.
42. Spilianakis CG, Flavell RA (2004) Long-range intrachromosomal interactions in the T helper type 2 cytokine locus. Nat Immunol 5: 1017-1027.
43. Vavouri T, McEwen GK, Woolfe A, Gilks WR, Elgar G (2006) Defining a genomic radius for long-range enhancer action: duplicated conserved non-coding elements hold the key. Trends Genet 22: 5-10.
44. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, et at. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297.
45. Nunez E, Kwon YS, Hutt KR, Hu Q, Cardamone MD, et al. (2008) Nuclear receptor-enhanced transcription requires motor- and LSD1-dependent gene networking in interchromatin granules. Cell 132: 996-1010.
46. Blow JJ, Dutta A (2005) Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 6: 476-486.
47. Weisz A, Bresciani F (1988) Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol Endocrinol 2: 816-824.
48. Weisz A, Rosales R (1990) Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-I transcription factor. Nucleic Acids Res 18: 5097-5106.
49. Bourdean V, Deschenes J, Laperriere D, Aid M, White JH, et at. (2008) Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells. Nucleic Acids Res 36: 76-93.
50. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, et al. (2002) Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62: 1289-1295.
51. Frasor J, Chang EC, Komm B, Lin CY, Vega VB, et at. (2006) Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res 66: 7334-7340.
52. Dubik D, Shiu RP (1992) Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594.
53. Klinge CM (2001) Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29: 2905-2919.
54. O'Lone R, Frith MC, Karlsson EK, Hansen U (2004) Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18: 1859-1875.
55. Gruher CJ, Gruber DM, Gruber IM, Wieser F, Huber JC (2004) Anatomy of the estrogen response element. Trends Endocrinol Metab 15: 73-78.
56. Sanchez R, Nguyen D, Rocha W, White JH, Mader S (2002) Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 24: 244-254.
57. Loven MA, Wood JR, Nardulli AM (2001) Interaction of estrogen receptors alpha and beta with estrogen response elements. Mol Cell Endocrinol 181: 151-163.
58. Carroll JS, Brown M (2006) Estrogen receptor target gene: an evolving concept. Mol Endocrinol 20: 1707-1714.
59. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, et al. (2005) Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A 102: 11651-11656.
60. Krikun G, Mor G, Alvero A, Guller S, Schatz F, et at. (2004) A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 145: 2291-2296.
61. Klinge CM, Silver BF, Driscoll MD, Sathya G, Banabara RA, et at. (1997) Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression. J Biol Chem 272: 31465-31474.
62. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, et at. (1999) The estrogen receptor enhances AP-I activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13: 1672-1685.
63. Safe S, Kim K (2004) Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Res Mol Biol 77: 1-36.
64. Deschenes J, Bourdeau V, White JH, Mader S (2007) Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences. J Biol Chem 282: 17335-17339.
65. Martinez E, Wahli W (1989) Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. Embo J 8: 3781-3791.
66. Shang Y, Brown M (2002) Molecular determinants for the tissue specificity of SERMs. Science 295: 2465-2468.
67. Nardulli AM, Romine LE, Carpo C, Greene GL, Rainish B (1996) Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Mol Endocrinol 10: 694-704.
68. Wood JR, Greene GL, Nardulli AM (1998) Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol 18: 1927-1934.
69. Wood JR, Likhite VS, Loven MA, Nardulli AM (2001) Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol Endocrinol 15: 1114-1126.
70. Kwon YS, Garcia-Bassets I, Hutt KR, Cheng CS, Jin M, et al. (2007) Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc Natl Acad Sci U S A 104: 48524-4857.
71. Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, et at. (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 3: e87.
72. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
73. Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7: 21-33.
74. Lund AH, van Lohuizen M (2004) Epigenetics and cancer. Genes Dev 18: 2315-2335.
75. Nair HB, Luthra R, Kirma N, Liu YG, Flowers L, et al. (2005) Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Cancer Res 65: 11164-11173.
76. Shimomura Y, Matsuo H, Samoto T, Maruo T (1998) Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab 83: 2192-2198.
77. Beral V, Bull D, Green J, Reeves G (2007) Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 369: 1703-1710.
78. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, et at. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43.
79. Norris J, Fan D, Aleman C, Marks JR, Futreal PA, et at. (1995) Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 270: 22777-22782.
80. Marks JR, Huper G, Vaughn JP, Davis PL, Norris J, et at. (1997) BRCA1 expression is not directly responsive to estrogen. Oncogene 14: 115-121.
81. Xu X, Bieda M, Jin VX, Rabinovich A, Oberley MJ, et at. (2007) A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res 17: 1550-1561.
82. Stender JD, Frasor J, Komm B, Chang KC, Kraus WL, et at. (2007) Estrogen Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell Proliferation. Mol Endocrinol 21: 2112-2123.
83. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, et at. (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/ M checkpoints. Genes Dev 16: 245-256.
84. Huang DY, Prystowsky MB (1996) Identification of an essential cis-element near the transcription start site for transcriptional activation of the proliferating cell nuclear antigen gene. J Biol Chem 271: 1218-1225.
85. Kamalakaran S, Radhakrishnan SK, Beck WT (2005) Identification of estrogen-responsive genes using a genome-wide analysis of promoter elements for transcription factor binding sites. J Biol Chem 280: 21491-21497.
86. Jin VX, Leu YW, Liyanarachchi S, Sun H, Fan M, et al. (2004) Identifying estrogen receptor alpha target genes-using integrated computational genomics and chromatin immunoprecipitation microarray. Nucleic Adds Res 32: 6627-6635.
87. Tang S, Tan SL, Ramadoss SK, Kumar AP, Tang MH, et al. (2004) Computational method for discovery of estrogen responsive genes. Nucleic Acids Res 32: 6212-6217.